文献速递眼整形与眼眶神经眼科

表观遗传调控Graves眼病眼眶成纤维细胞TSHR表达:治疗靶点

Epigenetic Modulation of Thyroid-Stimulating Hormone Receptor Expression in Orbital Fibroblasts From Graves' Ophthalmopathy: Target for Treatment.
PubMed 文献 · Invest Ophthalmol Vis Sci · 2026-01-01

本研究探讨DNA甲基转移酶(DNMTs)和组蛋白甲基转移酶EZH2调控Graves眼病(GO)患者眼眶成纤维细胞中促甲状腺激素受体(TSHR)和纤维化标志物表达的机制。发现活动期GO成纤维细胞中DNMT1和DNMT3A mRNA显著升高,DNMT1为主要亚型;PDGF-BB可诱导DNMT1和DNMT3A,地西他滨抑制PDGF-BB诱导的细胞活力和TSHR mRNA,DNMT1沉默部分降低TSHR蛋白;EZH2抑制也轻度降低TSHR mRNA。提示靶向DNMT/EZH2可能控制GO进展。

要点

  • 活动期GO眼眶成纤维细胞中DNMT1和DNMT3A mRNA显著高于非活动期和对照。
  • PDGF-BB刺激可诱导非活动期GO成纤维细胞中DNMT1和DNMT3A mRNA表达。
  • 地西他滨抑制PDGF-BB诱导的细胞活力和TSHR mRNA,DNMT1沉默部分降低TSHR蛋白。

核心结论

  • DNMT1是GO活动期的主要DNMT,且可被PDGF-BB诱导,提示PDGF-BB和DNMT1在GO活动期起重要作用。
  • 抑制DNMT或EZH2可抑制TSHR mRNA表达,提示靶向DNMT/EZH2可能控制GO进展。

研究设计与样本

  • 研究比较健康对照、活动期GO和非活动期GO眼眶成纤维细胞中DNMTs mRNA水平。
  • 在非活动期GO成纤维细胞中用PDGF-BB及地西他滨、DZNep或小干扰RNA处理,通过RT-qPCR或Western blotting检测TSHR和纤维化标志物。

主要发现

  • 活动期GO成纤维细胞中DNMT1和DNMT3A mRNA表达显著高于非活动期GO和对照成纤维细胞,其中DNMT1表达水平最高。
  • PDGF-BB刺激后非活动期GO成纤维细胞中DNMT1和DNMT3A mRNA水平显著诱导。
  • 地西他滨显著抑制PDGF-BB诱导的非活动期GO成纤维细胞细胞活力和TSHR mRNA水平,DNMT1沉默部分降低TSHR蛋白。
  • 非活动期GO成纤维细胞中DNMT1与EZH2表达呈正相关;DZNep轻度降低非活动期GO成纤维细胞和GO眼眶组织中TSHR mRNA表达,EZH2沉默部分影响TSHR表达。

临床怎么用

  • 活动期GO中DNMT1高表达且可被PDGF-BB诱导,提示其作为活动期标志或治疗靶点的潜在价值。
  • 抑制DNMT或EZH2可降低TSHR mRNA,支持表观遗传干预作为控制GO进展的潜在策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aims to investigate the expression and function of DNA methyltransferases (DNMTs) and histone methyltransferase EZH2 in regulating the expression of thyroid-stimulating hormone receptor (TSHR) and fibrotic markers by orbital fibroblasts from Graves' ophthalmopathy (GO) patients. METHODS: DNMTs mRNA levels were measured in orbital fibroblasts from healthy controls (control orbital fibroblasts), active GO fibroblasts, and inactive GO fibroblasts (iGOFs). TSHR and other fibrotic markers were measured in iGOFs treated with platelet-derived growth factor (PDGF)-BB and decitabine (a DNMT inhibitor) or DZNep (an EZH2 inhibitor) or small interfering RNA by RT-qPCR or Western blotting. RESULTS: DNMT1 and DNMT3A mRNA expressions were significantly higher in active GOFs compared with iGOFs and control orbital fibroblasts. Among all DNMTs, DNMT1 expression was at the highest levels. Upon PDGF-BB stimulation, DNMT1 and DNMT3A mRNA levels in iGOFs were significantly induced. Decitabine significantly inhibited PDGF-BB-induced cell viability and TSHR mRNA levels in iGOFs, whereas DNMT1 silencing partly reduced TSHR protein. Because a positive correlation between DNMT1 and EZH2 expression in iGOF was observed, the regulatory role of EZH2 on TSHR expression was also investigated. DZNep slightly decreased TSHR mRNA expression in iGOFs and iGO orbital tissue, whereas EZH2 silencing partly affects TSHR expression. CONCLUSIONS: This study demonstrates that DNMT1 is the major DNMT during the active stage of GO. Moreover, DNMT1 is inducible upon PDGF-BB stimulation in iGOFs, suggesting an important role of PDGF-BB and DNMT1 during an active stage of GO. Our findings also highlighted that the inhibition of DNMT or EZH2 potentially suppressed TSHR mRNA expression, suggesting potential therapies targeting DNMT/EZH2 in controlling GO progression.

来源:Invest Ophthalmol Vis Sci,查看原文。版权归原作者所有。

引用

  1. Chompoowong R, Phankeaw P, Suwannavong A, et al. Epigenetic Modulation of Thyroid-Stimulating Hormone Receptor Expression in Orbital Fibroblasts From Graves' Ophthalmopathy: Target for Treatment. Invest Ophthalmol Vis Sci. 2026. PMID: 42565655. doi:10.1167/iovs.67.10.21

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。